Novo Nordisk Woes Just Hit Denmark’s Economy. Its Stock Is Rising. - Barron's
1. Novo Nordisk impacts Denmark's economy but faces recent quarterly contraction. 2. Danish GDP fell 0.5% due to pharmaceutical industry decline. 3. Novo's sales fell 9% sequentially but grew 19% year-over-year. 4. Novo lowered expected sales growth for the year amid increased competition. 5. A new CEO is sought as shares are down 55% since mid-2024.